Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.48 USD | -0.26% | +2.99% | +9.41% |
May. 09 | Morgan Stanley Boosts Price Target on Avient to $47 From $40, Keeps Equalweight Rating | MT |
May. 08 | Wells Fargo Raises Price Target on Avient to $52 From $50, Maintains Overweight Rating | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company sustains low margins.
- The company is in debt and has limited leeway for investment
- The firm trades with high earnings multiples: 25.99 times its 2024 earnings per share.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.41% | 4.15B | A- | ||
+1.61% | 49.2B | A- | ||
+16.33% | 41.24B | B+ | ||
+18.68% | 25.89B | A- | ||
+12.78% | 19.81B | C+ | ||
+0.85% | 17.48B | B+ | ||
-21.87% | 15.86B | A- | ||
+2.32% | 15.35B | B+ | ||
-10.29% | 15.23B | C+ | ||
-22.30% | 13.36B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AVNT Stock
- Ratings Avient Corporation